Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 7
1991 5
1992 11
1993 10
1994 22
1995 10
1996 6
1997 13
1998 21
1999 17
2000 38
2001 39
2002 35
2003 40
2004 38
2005 43
2006 47
2007 30
2008 56
2009 49
2010 33
2011 33
2012 32
2013 24
2014 23
2015 22
2016 28
2017 24
2018 21
2019 24
2020 21
2021 22
2022 12
2023 14
2024 13
2025 16
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

790 results

Results by year

Filters applied: . Clear all
Page 1
Cetrorelix in the treatment of female infertility and endometriosis.
Finas D, Hornung D, Diedrich K, Schultze-Mosgau A. Finas D, et al. Expert Opin Pharmacother. 2006 Oct;7(15):2155-68. doi: 10.1517/14656566.7.15.2155. Expert Opin Pharmacother. 2006. PMID: 17020439 Review.
The use of cetrorelix within ovarian-stimulation protocols demonstrates several advantages compared with gonadotropin-releasing hormone (GnRH) agonist-containing protocols, which include, for example, significantly less time for analogue treatment and a reduction in the am …
The use of cetrorelix within ovarian-stimulation protocols demonstrates several advantages compared with gonadotropin-releasing hormo …
GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.
Tur-Kaspa I, Ezcurra D. Tur-Kaspa I, et al. Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1323-36. doi: 10.1517/17425250903279969. Expert Opin Drug Metab Toxicol. 2009. PMID: 19761413 Review.
METHOD: A review of published literature on cetrorelix. RESULTS: Both multiple- and single-dose cetrorelix protocols were shown to be at least as effective as long GnRH agonist regimens for pituitary suppression in Phase II/III clinical trials. ...A single-dose c …
METHOD: A review of published literature on cetrorelix. RESULTS: Both multiple- and single-dose cetrorelix protocols were show …
The LHRH antagonist cetrorelix: a review.
Reissmann T, Schally AV, Bouchard P, Riethmiiller H, Engel J. Reissmann T, et al. Hum Reprod Update. 2000 Jul-Aug;6(4):322-31. doi: 10.1093/humupd/6.4.322. Hum Reprod Update. 2000. PMID: 10972520 Review.
One of the most advanced antagonist produced to date is Cetrorelix, a decapeptide which has been shown to be safe and effective in inhibiting LH and sex-steroid secretion in a variety of animal species and in clinical studies as well. ...Following completion of phase III t …
One of the most advanced antagonist produced to date is Cetrorelix, a decapeptide which has been shown to be safe and effective in in …
Effect of Cetrorelix administration on ovarian stimulation in aged mice.
Kanda A, Nobukiyo A, Sotomaru Y. Kanda A, et al. Exp Anim. 2021 Feb 6;70(1):31-36. doi: 10.1538/expanim.20-0058. Epub 2020 Aug 31. Exp Anim. 2021. PMID: 32863284 Free PMC article.
Collagen staining of ovarian tissue showed that Cetrorelix administration reduced the degree of fibrosis, which improved ovarian function. ...It is concluded that Cetrorelix improved the effect of superovulation in aged mice without reducing oocyte quality. ...
Collagen staining of ovarian tissue showed that Cetrorelix administration reduced the degree of fibrosis, which improved ovarian func …
GnRH antagonists.
Devroey P. Devroey P. Fertil Steril. 2000 Jan;73(1):15-7. doi: 10.1016/s0015-0282(99)00448-3. Fertil Steril. 2000. PMID: 10632404 Free article. No abstract available.
Effects of Cetrorelix on Ovary and Endometrium Prior to Anti-PD-L1 Antibody in Murine Model.
Park SJ, Kim YY, Park W, Park S, Han JY, Kim SW, Kim H, Ku SY. Park SJ, et al. Tissue Eng Regen Med. 2024 Feb;21(2):319-328. doi: 10.1007/s13770-023-00617-x. Epub 2023 Dec 16. Tissue Eng Regen Med. 2024. PMID: 38103140 Free PMC article.
In this study, we attempted to elucidate the protective or regenerative effect on the female reproductive organ of cetrorelix prior to anti-PD-L1 antibody administration. METHOD: Using a murine model, we examined the effects of Anti-PD-L1 antibody treatment on ovarian and …
In this study, we attempted to elucidate the protective or regenerative effect on the female reproductive organ of cetrorelix prior t …
Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction.
Bukulmez O, Carr BR, Doody KM, Doody KJ. Bukulmez O, et al. Fertil Steril. 2008 Jan;89(1):74-83. doi: 10.1016/j.fertnstert.2007.02.017. Epub 2007 Jul 26. Fertil Steril. 2008. PMID: 17662281 Free article.
OBJECTIVE: To analyze the potential association between serum cetrorelix levels and clinical pregnancy outcome in patients who had undergone assisted reproduction cycles with a GnRH antagonist cetrorelix acetate 3-mg injection. ...RESULT(S): The cetrorelix se …
OBJECTIVE: To analyze the potential association between serum cetrorelix levels and clinical pregnancy outcome in patients who had un …
Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study.
Huirne JA, Hugues JN, Pirard C, Fischl F, Sage JC, Pouly JL, Obruca A, Braat DM, van Loenen AC, Lambalk CB. Huirne JA, et al. Hum Reprod. 2006 Jun;21(6):1408-15. doi: 10.1093/humrep/del030. Epub 2006 Mar 14. Hum Reprod. 2006. PMID: 16537563 Clinical Trial.
One hundred and eighty two patients were randomized to receive cetrorelix with OC pretreatment (n = 91) or to receive buserelin (n = 91). The cetrorelix group started with daily OCs on cycle day 5 and continued for 21-28 days. Cetrorelix (0.25 mg) was given d …
One hundred and eighty two patients were randomized to receive cetrorelix with OC pretreatment (n = 91) or to receive buserelin (n = …
Double daily doses of cetrorelix may raise follicular phase progesterone more compared to single doses in poor ovarian response patients.
Ozturk M, Fidan U, Ceyhan T, Ozturk O, Karasahin E, Ozcan L, Korkmaz C. Ozturk M, et al. J Gynecol Obstet Hum Reprod. 2021 Dec;50(10):102223. doi: 10.1016/j.jogoh.2021.102223. Epub 2021 Sep 9. J Gynecol Obstet Hum Reprod. 2021. PMID: 34509694
However, a double daily dose of cetrorelix seems to cause FPPR in poor ovarian response (POR) patients. MATERIALS AND METHODS: On human chorionic gonadotropin [hCG] injection days, the progesterone levels of POR patients who received a single daily dose of cetrorelix …
However, a double daily dose of cetrorelix seems to cause FPPR in poor ovarian response (POR) patients. MATERIALS AND METHODS: On hum …
[Endometriosis].
Osuga Y. Osuga Y. Nihon Rinsho. 2006 Apr;64 Suppl 4:112-5. Nihon Rinsho. 2006. PMID: 16689294 Review. Japanese. No abstract available.
790 results